Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2013

InVivo Therapeutics Holdings Corp. (NVIV) Gives Update on Clinical Timeline for Spinal Cord Injury Treatment

InVivo Therapeutics Holdings is a medical technology company focused on utilizing polymers as a platform technology to develop treatments to improve function in patients paralyzed as a result of traumatic spinal cord injury. In 2011, the company earned the prestigious … Continue reading

Posted in Small Cap News | Leave a comment

Taglich Brothers Reiterates Buy Rating on OxySure Systems, Inc. (OXYS); Target Price $2.10 Per Share

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, was reiterated with a Speculative Buy rating from analysts at Taglich Brothers. Taglich Brothers set … Continue reading

Posted in OxySure Systems Inc. OXYS | Leave a comment

Response Genetics, Inc. (RGDX) Expands Testing Base with Acquisition of Pathwork Diagnostics Assets

Response Genetics, a CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer, has acquired the core assets of Pathwork Diagnostics, including its FDA-cleared cancer diagnostic test, for a $200,000 cash payment and issuance … Continue reading

Posted in Small Cap News | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Targets Outdated Drug Testing Paradigm

The pharmaceutical industry’s current drug development paradigm is supposed to assess whether a drug candidate is both safe and effective for use in the treatment of a given disease. It’s an approach that has been used for many years, involving … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

LoJack Corp. (LOJN) Announces Matter Communications as AOR

Public relations and social media agency Matter Communications announced earlier today that it is the Agency of Record (AOR) for LoJack Corporation, the company that pioneered the Stolen Vehicle Recovery market. LoJack selected the agency as its AOR after an … Continue reading

Posted in Small Cap News | Leave a comment

Initial Success Shown in Second Phase of Oragenics, Inc. (OGEN) Collaboration’s Lantibiotics Project

Through the exclusive channel collaboration (ECC) between Oragenics and synthetic biology company Intrexon, preliminary experiments are demonstrating that a genetically modified (GM) host can be engineered to produce improved titers of MU1140 – OGEN’s lead compound – progressing toward the … Continue reading

Posted in Small Cap News | Leave a comment

China Commercial Credit, Inc. (CCCR) Poised to Capture Massive Territory in Booming Jiangsu Microcredit Space

China Commercial Credit has amassed a considerable microcredit empire in the thriving eastern coastal province of Jiangsu. Founded only five years ago, the company now services over 360 SME (small-to-medium enterprise) clients, as well as farmers and individuals with direct … Continue reading

Posted in Small Cap News | Leave a comment

Hansen Medical, Inc. (HNSN) Upgrades Debt Facility, Interest-Only $33M Secured Through Dec 2017

Hansen Medical, one of the top companies on the planet in intravascular robotic and electrophysiology systems, reported today on the successful closure of a long-term debt agreement with San Francisco-based, SEC-registered specialty lending products and investment management services firm, White … Continue reading

Posted in Small Cap News | Leave a comment

Burcon NutraScience Corp. (BUR) Semi-Works Plant Now Operational

Leader in developing functionally and nutritionally valuable plant-based proteins, Burcon NutraScience (TSX:BU) (Nasdaq:BUR), has completed the startup and commissioning of its semi-works plant in Winnipeg for its pea protein Peazazz®, meeting initial scheduling goals. The newly commissioned plant will provide … Continue reading

Posted in Small Cap News | Leave a comment

Cardium Therapeutics, Inc. (CXM) Subsidiary Enters Commercialization Agreement for Life Insurance Products

Cardium Therapeutics recently announced that its wholly-owned subsidiary, LifeAgain™ Insurance Solutions Inc., has entered into a commercialization agreement with AgencyONE. The agreement will have LifeAgain™ supporting the development and commercialization of innovative, survivable risk life insurance products based on Cardium’s … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment